The American Medical Association classified obesity as a disease in 2013. Here is why that classification matters, what the biology shows about why obesity is not a choice, and what it means for how treatment should work.

In 2013, the American Medical Association voted to classify obesity as a chronic disease. The decision was not unanimous and it remains debated in some quarters. But the biological evidence that underpinned it has only grown stronger in the years since, and the implications of that classification for how patients are treated, and how they think about themselves, are significant enough to be worth examining directly.

What the Disease Classification Actually Means

Classifying obesity as a disease does not mean that lifestyle choices are irrelevant to weight. They are relevant, in the same way that lifestyle choices are relevant to type 2 diabetes, hypertension, and heart disease. Those conditions also have strong lifestyle components. They are also diseases.

What the classification recognizes is that obesity involves identifiable physiological abnormalities, that it impairs normal body function and produces serious health complications, and that it does not consistently resolve with willpower and behavioral effort alone, in the same way that other chronic diseases do not consistently resolve without targeted treatment.

The alternative model, in which excess weight is primarily a character and motivation problem, has been tested at scale for decades through public health messaging, diet programs, and behavioral interventions. The outcomes of that model are well documented and consistently poor. The majority of people who lose weight through behavioral intervention alone regain it within five years. This is not because most people lack the desire to maintain their results. It is because the biological systems that regulate weight actively resist the change.

The Biological Basis of the Disease Classification

Several decades of neuroendocrinology research established the physiological case for obesity as a disease. The key findings are worth summarizing.

The hypothalamic set point for body weight is actively defended by multiple redundant biological systems. When weight falls below the defended set point, hunger increases, resting metabolic rate decreases, and the biological drive to restore lost weight intensifies. This is not a temporary adjustment. Research tracking people years after significant diet-induced weight loss finds that the hunger hormones that increased during the weight loss period remain elevated, and the hormones that reduce appetite remain suppressed, years after the weight loss was achieved. The body is still trying to get back to the previous weight.

Leptin resistance, as described in the appetite article, means that fat tissue can be producing adequate amounts of the satiety hormone leptin but the brain is not receiving or responding to the signal normally. The brain essentially experiences a state of energy deficiency even when energy stores are abundant.

The gut microbiome, as discussed separately, is altered in obesity in ways that appear to contribute causally to weight maintenance and regain rather than being simply a passive reflection of weight status.

Genetic factors contribute meaningfully to obesity risk, with twin studies and genome-wide association studies identifying hundreds of genetic variants associated with higher BMI. None of these variants are deterministic, and their effects are modified by environment and behavior, but the substantial heritable component of obesity means that the same caloric environment produces very different outcomes in different people based on their biology.

What the Disease Framework Changes About Treatment

Framing obesity as a disease rather than a behavioral failure changes the treatment approach in several ways that are clinically significant.

It justifies treatment rather than simply advice. A physician who recognizes obesity as a disease has a basis for prescribing effective treatment including GLP-1 medications, rather than simply telling patients to try harder with approaches that have already failed.

It removes the moral weight from the patient's shoulders in a way that reduces the shame that is one of the most significant barriers to seeking care. Research on healthcare engagement consistently shows that patients who experience shame around their condition are less likely to seek treatment, less likely to disclose relevant information to providers, and less likely to follow through with recommended interventions.

It sets appropriate expectations for treatment duration. Chronic diseases require sustained management. A patient with hypertension is not expected to take blood pressure medication for six months and then manage independently forever. The biological evidence on GLP-1 therapy and weight regain, as discussed in the weight regain article, supports similarly sustained treatment approaches for appropriate patients.

What This Means for Patients on EllieMD's Program

EllieMD's approach is built on the disease framework. The physician oversight, the ongoing clinical relationship, the community support structure, and the availability of effective pharmacological tools all reflect a model in which obesity is treated as a serious, complex, biologically driven condition rather than a willpower problem awaiting a motivational solution.

For patients who have spent years feeling that their weight was a personal failure, this reframe is not just semantics. It is a more accurate account of the biology, and it is the foundation on which effective treatment is built. Understanding that the difficulty you experienced with previous weight loss attempts reflected a genuine biological challenge, not a character deficiency, changes how you engage with treatment, how you interpret setbacks, and how you communicate with your physician.

Individual results may vary. All prescriptions require approval by a licensed medical provider. Compounded medications are not FDA-approved. EllieMD facilitates access to independent healthcare providers and pharmacies and does not provide medical care or dispense medications.